INOZYME
Inozyme is a provider of therapies for rare diseases of calcification affecting soft tissues and bone created to offer potentially disease-modifying therapies to help children who are affected with rare, but severe and debilitating disorders of metabolism. The company's enzyme replacement therapy provides the treatment of Generalized Arterial Calcification of Infancy (GACI) and Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2), enabling patients to treat diseases characterized by mineral imbalances in the body.
INOZYME
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2016-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.inozyme.com
Total Employee:
11+
Status:
Active
Contact:
+1 (857) 330-4340
Email Addresses:
[email protected]
Total Funding:
220.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
Aprea
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
ZS Pharma
ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - Inozyme
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series A - Inozyme
RA Capital Management
RA Capital Management investment in Series A - Inozyme
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series A - Inozyme
Sofinnova Investments
Sofinnova Investments investment in Series A - Inozyme
Sanofi Ventures
Sanofi Ventures investment in Series A - Inozyme
New Enterprise Associates
New Enterprise Associates investment in Series A - Inozyme
Rock Springs Capital
Rock Springs Capital investment in Series A - Inozyme
Longitude Capital
Longitude Capital investment in Series A - Inozyme
Novo Holdings
Novo Holdings investment in Series A - Inozyme
Key Employee Changes
Official Site Inspections
http://www.inozyme.com Semrush global rank: 4.29 M Semrush visits lastest month: 2.68 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago